KAREN FULLER: Open Payments
NPI 1831731306 · DALLAS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$433 in 23 payments from 11 companies in 2025. Trend: 2023 $459 · 2024 $356 · 2025 $433
Food & beverage: $433
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $89 |
| Collegium Pharmaceutical, Inc. | 4 | $78 |
| Astellas Pharma US Inc | 2 | $55 |
| PFIZER INC. | 3 | $50 |
| Lilly USA, LLC | 2 | $35 |
| GlaxoSmithKline, LLC. | 2 | $31 |
| Corium, LLC | 2 | $28 |
| SHIELD THERAPEUTICS INC | 1 | $21 |
| Supernus Pharmaceuticals, Inc. | 1 | $16 |
| Exact Sciences Corporation | 1 | $16 |
Products named: Jornay PM, Ozempic, Veozah, JARDIANCE, Azstarys, ACCRUFER, PREVNAR 20, SHINGRIX.
Industry payments across GA — which companies pay providers there.
